Literature DB >> 10425173

A peptide of the alpha3 chain of type IV collagen protects basement membrane against damage by PMN.

Z Ziaie1, A Fawzi, G Bellon, J C Monboisse, N A Kefalides.   

Abstract

We have shown that basement membrane (BM) collagen (type IV), and specifically the peptide CNYYSNSYSFWLASLNPER (a.a. 185-203), from the non-collagenous domain of the alpha3 chain inhibits PMN. We examined the role of this peptide on PMN damage to BM in a vessel wall model. The presence of the endothelial monolayer as well as treatment of PMN with the alpha3(IV) 185-203 peptide reduced damage to BM by non-activated but not by activated PMN. The damage inhibition is unique to the alpha3(IV) peptide and not exhibited by comparable alpha1(IV) and alpha2(IV) chain peptides. A shorter peptide alpha3(IV) 185-191, containing the -SNS- triplet, reduced damage, whereas the one lacking the triplet, residues 194-203, was not effective. The CD47-alphavbeta3 integrin complex is the receptor for the alpha3(IV) peptide. Incubation of PMN with CD47 reactive mAb followed by the alpha3(IV) peptide abolished its protective effect on BM damage. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10425173     DOI: 10.1006/bbrc.1999.1029

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

Review 1.  Regulation of endothelial cell functions by basement membrane- and arachidonic acid-derived products.

Authors:  Ambra Pozzi; Roy Zent
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2009 Sep-Oct

2.  The Effects of Tumstatin on Vascularity, Airway Inflammation and Lung Function in an Experimental Sheep Model of Chronic Asthma.

Authors:  Joanne Van der Velden; Louise M Harkness; Donna M Barker; Garry J Barcham; Cathryn L Ugalde; Emmanuel Koumoundouros; Heidi Bao; Louise A Organ; Ana Tokanovic; Janette K Burgess; Kenneth J Snibson
Journal:  Sci Rep       Date:  2016-05-20       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.